Tissue Integration is a fundamental concept in regenerative medicine and tissue engineering, referring to the successful incorporation of engineered or transplanted tissues into the host organism. The goal is to achieve seamless integration between the artificial construct and the surrounding native tissue, ensuring proper functionality and avoiding adverse reactions. Scaffold materials play a crucial role in tissue integration, providing a framework for cell attachment, proliferation, and differentiation. Surface modifications, such as coatings with bioactive molecules or extracellular matrix components, are often employed to enhance the integration process. Cellular components, including stem cells or specific differentiated cell types, contribute to tissue integration by actively participating in the regeneration and remodeling of the host tissue. Vascularization is a critical aspect of tissue integration, ensuring an adequate blood supply for the survival and functionality of the engineered tissue. Mechanical properties of the construct, such as flexibility and strength, are carefully considered to promote compatibility with the surrounding tissue. Monitoring techniques, including imaging modalities and biomarker assessments, help evaluate the extent and quality of tissue integration over time. Successful tissue integration is crucial for the clinical success of various regenerative therapies, such as organ transplantation, tissue replacement, and the development of implantable medical devices. Ongoing research in tissue integration focuses on refining strategies, biomaterials, and technologies to improve the long-term outcomes and clinical applicability of tissue-engineered constructs.
Title : AI-integrated high-throughput tissue-chip for space-based biomanufacturing applications
Kunal Mitra, Florida Tech, United States
Title : Stem cell technologies to integrate biodesign related tissue engineering within the frame of cell based regenerative medicine: towards the preventive therapeutic and rehabilitative resources and benefits
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : In vitro evaluation of lyophilized Dedifferentiated Fat cells (DFAT) impregnated artificial dermis
Kazutaka Soejima, Nihon University, School of Medicine, Japan
Title :
Nagy Habib, Imperial College London, United Kingdom
Title :
Alexander Seifalian, Nanotechnology & Regenerative Medicine Commercialisation Centre, United Kingdom
Title : The regenerative medicine of the future
Marco Polettini, DVM, Italy